<bill session="112" type="h" number="1862" updated="2011-06-03T06:19:14-04:00">
	<state datetime="2011-05-12">REFERRED</state>
	<status><introduced datetime="2011-05-12"/></status>

	<introduced datetime="2011-05-12"/>
	<titles>
		<title type="short" as="introduced">Regenerative Medicine Promotion Act of 2011</title>
		<title type="official" as="introduced">To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes.</title>
	</titles>
	<sponsor id="400570"/>
	<cosponsors>
		<cosponsor id="400648" joined="2011-05-12"/>
		<cosponsor id="400147" joined="2011-05-12"/>
		<cosponsor id="400230" joined="2011-05-12"/>
		<cosponsor id="400616" joined="2011-05-12"/>
		<cosponsor id="412327" joined="2011-05-12"/>
		<cosponsor id="400124" joined="2011-06-02"/>
		<cosponsor id="400101" joined="2011-05-12"/>
		<cosponsor id="400184" joined="2011-05-12"/>
	</cosponsors>
	<actions>
		<action datetime="2011-05-12"><text>Referred to the House Committee on Energy and Commerce.</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Health"/>
		<term name="Advisory bodies"/>
		<term name="Department of Health and Human Services"/>
		<term name="Drug safety, medical device, and laboratory regulation"/>
		<term name="Executive agency funding and structure"/>
		<term name="Genetics"/>
		<term name="Health programs administration and funding"/>
		<term name="Health technology, devices, supplies"/>
		<term name="Medical research"/>
		<term name="Product development and innovation"/>
		<term name="Research administration and funding"/>
		<term name="Research and development"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	
	</summary>
</bill>
